Employing Small Molecule Design as a Safeguard Against Toxicity of TGF-β Targeted Therapies
Time: 11:30 am
day: Conference Day Two
Details:
- Targeting TGF-β activation to reduce unwanted side effects
- Making treatments directed to TGF-β safe and efficacious by stimulating T cell responses and reducing fibrosis
- Exploring response of αvβ8 inhibitor in mouse tumor models
